Patients Suffer as Dea Unexplained Delays MMJ’s Marijuana Research, Clinical Trials, and Pharmaceutical Development

 Patients Suffer as Dea Unexplained Delays MMJ’s Marijuana Research, Clinical Trials, and Pharmaceutical Development

PROVIDENCE, RI / ACCESSWIRE / September 6, 2022 / Duane Boise, MMJ companies President echoing the NIH directors recent statements remarked, “Unfortunately MMJ was forced to file suit against the DEA…